Aims: To evaluate safety and efficacy of moderate intensity interval exercise training early after heart failure decompensation on exercise tolerance and health-related quality of life (HRQoL). Methods and results: This is a prospective randomized controlled study. We screened 234 consecutive patients admitted with decompensated heart failure; 46 patients (42 men/4 women; 61 AE 12 years of age) were randomized to a moderate intensity aerobic interval training (n ¼ 24) or to a control group (n ¼ 22). Patients underwent cardiopulmonary exercise testing, echocardiography and Minnesota Living with Heart Failure questionnaire (MLHFQ) at baseline, after three weeks and after three months. After three weeks, peak-VO 2 increased by 17% in the training group (p ¼ 0.003) with further increase by 10% after three months (p < 0.001) but did not change significantly in controls. MLHFQ score improved after three weeks, with better results in the training group (from 64.6 AE 15.6 to 30.8 AE 12.9, p < 0.001). After three months, MLHFQ further improved in the exercise training group, but not in controls. Left ventricular ejection fraction was not significantly different between the two groups at baseline and after three months. No serious adverse events related to exercise testing or training were observed. Conclusions: Interval exercise training early after an episode of heart failure decompensation is safe and effective in improving exercise tolerance and health-related quality of life in selected patients after achievement of clinical stability. Positive effects remained sustained after three months. Further studies are needed to define role and indications for interval exercise training early after heart failure decompensation.
Introduction
Exercise training is a recognized treatment modality in clinically stable heart failure patients and contributes to an improvement of exercise tolerance, to an increase in health related quality of life (HRQoL), and to a reduction of re-hospitalization rate, with a trend towards reduction of mortality in trials where follow-up was longer than 12 months. 1, 2 Gradual mobilization of patient with careful individualized approach is recommended for patients with severe heart failure, especially after a recent decompensation. 1, 3, 4 Nevertheless, important issues in regard to timing and modality of training for heart failure patients are still uncertain. In particular, it is unclear how early exercise training can be started after an episode of heart failure decompensation. According to the guidelines and statements for training 1 Cardiology Clinic, IM Sechenov First Moscow State Medical University, Russia 2 Cardiology Clinic, University Hospital Bern, Switzerland in heart failure patients, a stability of clinical condition is required for at least 3-5 days (which includes absence of body weight gain, no progressive decrease of exercise tolerance or increased dyspnoea and no inotropic drugs). However, a gap between knowledge and clinical implications clearly exists 5 and exercise based cardiac rehabilitation usually starts only after a period of 1-3 months in stable conditions. [5] [6] [7] Therefore, the aim of this study was to evaluate safety and efficacy of a short-term interval exercise training programme early after an episode of heart failure decompensation to improve exercise tolerance and HRQoL.
Methods

Subjects
We consecutively screened a cohort of patients with reduced ejection fraction and admitted to the Cardiology Clinic of IM Sechenov First Moscow State Medical University for heart failure decompensation. Decompensation was defined as congestive heart failure with moderate or severe symptoms attributable to class III or IV according to the New York Heart Association (NYHA) classification. Diagnosis of chronic heart failure and treatment regimen were established according to the actual guidelines of the European Society of Cardiology. 3 The study was conducted in accordance with the Declaration of Helsinki and has been approved by the institutional ethics committee. All patients provided written informed consent to participate in the study.
Criteria of inclusion were: 1) age 18-85 years, 2) recent hospitalization for decompensated systolic chronic heart failure, 3) stable clinical state including absence of symptoms of heart failure at rest, absence of inotropic agents, no intravenous diuretics, stable weight and stable dosage of oral diuretics for at least three days (change from NYHA class IV to class II or III), 4) ability to perform exercise testing. Exclusion criteria apart from not meeting inclusion criteria were: 1) cardiac surgery or cardiac resynchronization therapy (CRT) within the previous two months, 2) being in need of any cardiac surgery or revascularization, 3) acute myocardial infarction within one month, 4) diagnosis of heart failure due to severe valvular disease, hypertrophic or restrictive cardiomyopathy, 5) malignant ventricular arrhythmias, 6) exercise capacity limited by other disease or illness, 7) low estimated 9 glomerular filtration rate (<30 ml/min per 1.73 m 2 ), 8) severe anaemia with haemoglobin level less than 90 mg/dl, severe chronic obstructive pulmonary disease (FEV 1 <40%), 9) unstable diabetes mellitus (glycated Hb >12%), 10) acute infection, 11) active cancer with life expectancy less than one year; 12) standard contraindications to exercise testing and training, and 13) expected low compliance and/or alcohol abuse according to anamnestic data or inability to travel to the hospital after discharge.
Assessment of exercise tolerance
Patients underwent clinical examination, six-minute walking test (6MWT) and cardio-pulmonary exercisetesting (CPX), all performed consecutively on the same day by an independent investigator who was blinded in regard to group allocation. Tests were scheduled at least 3 h and no longer than 6 h after taking morning medication to ensure equal beta-blocker effect. Tests were performed at least 2 h after a light breakfast and preceded by a 15-min rest period. Patients were also allowed to have a 40-min break between the two tests.
6MWT 8 was conducted in a 75 m-long hospital corridor. Patients were instructed to walk as far as possible during 6 min without running but with the possibility of slowing down and having a rest.
CPX was conducted on a treadmill (Intertrack 8100, Schiller, Switzerland) with breath-by-breath algorithm of gas exchange analysis (Cardiovit CS-200 Ergo-Spiro, Schiller, Switzerland), using a modified Naughton protocol 9 with steep (not step-wise) increase of the load. 10 Patient's effort counted as substantial if selfreported number by 6-20 Borg scale was >17 points 10 and Respiratory Exchange Ratio (RER) >1.0.
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Echocardiography
Conventional 2D-echocardiography (ECHO) was performed in the morning before the 6MWT (Vivid 7, GE, USA). ECHO data analysis was performed by an expert blinded to the group allocation. Left ventricle (LV) end diastolic volume (LVEDV), end systolic volume (LVESV) and ejection fraction (LVEF) were measured with the modified Simpson method, using the four-and two-chamber views. 12 
Quality of life assessment
HRQoL was assessed using the Minnesota Living with Heart Failure questionnaire (MLHFQ) 13 before any study procedure in order to exclude an impact of selfimpression on exercise test performance. We used the Russian version 2.0 for Russia, distributed by Mapi Research Trust. 14 All tests, including 6MWT, CPX, ECHO and HRQoL assessment, were repeated three weeks and three months after baseline examinations.
Intervention
This is a prospective randomized controlled trial. Patients were randomized into training group and controls.
The start of the training period was defined by clinical stability presenting in recovery from NYHA IV class to NYHA III-II classes. Patients randomized for training started to exercise the day after performing the CPX test. The training regimen was defined using the ramp-test on a bicycle ergometer (Ergosana Gmbh, Germany): 1 min of unloaded pedalling was followed by increasing the load in a steep manner by 25 W every 10 s. The test was terminated if the patient was tired or unable to maintain the given speed of pedalling (55-65 rounds per minute) and maximal load in watts was registered. Exercise intensity of interval training was set at 50% of the maximal load achieved during the ramp-test.
Each training session consisted of a 3-min warm-up period, a training period and a 2-min recovery period. Training periods consisted of 20-s exercise phases each followed by 40 s of rest pedalling with 10 W load. The duration of training periods was defined by CPX: 10 min for patients with VO 2 peak <10 ml/kg Â min, 15 min for patients with VO 2 peak 10-14 ml/kg Â min, and 20 min for patients with VO 2 peak >14 ml/kg Â min. 15 Ramptests were repeated at the beginning of the second and third weeks of training to adjust exercise load; exercise time was increased up to 5-10 minutes on the basis of individual tolerance. Interval training continued for three weeks, five days per week (excepting weekends), starting as an in-patient and continuing as an outpatient after discharge from the hospital, resulting in a total of 15 sessions for each patient in the training group.
All patients received physical activity recommendations: patients in the intervention group after completing the exercise programme and patients in the control group at discharge. All patients were followed by regular weekly phone calls and monthly visits to the hospital. Titration of beta-blocker and angiotensin-converting enzyme inhibitor dosages and other corrections in medical therapy were performed as needed.
Statistical analysis
Statistical analysis was performed using Statistical Package for the Social Sciences version 22 (IBM SPSS Statistics, USA). The continuous data were expressed as a mean value AE standard deviation. Other data are presented in absolute numbers and proportions of characteristics. Mann-Whitney U test was used to compare training and control groups. Wilcoxon criterion was used to compare baseline, three-week and threemonth results within groups. Tests were two-tailed and a p-value <0.05 was considered significant.
Results
Two hundred and thirty-four patients were hospitalized for decompensated heart failure and screened for the study during the inclusion period. Out of 234 patients 182 (77.8%) did not meet inclusion criteria and six patients (2.6%) refused to participate due to long travelling distance. A study flow diagram is presented in Figure 1 .
The most important reasons for not meeting inclusion criteria were: valvular heart disease (21%), orthopaedic or neurological problems limiting exercise performance (10%), low glomerular filtration rate (GFR) (10%), acute myocardial infarction (7%), severe chronic obstructive pulmonary disease (6%), decompensated diabetes mellitus (5%), low compliance (5%), cancer (4%), uncontrolled potentially life-threatening heart rhythm or conduction disturbances (4%), alcohol abuse (4%), cardiac surgery less than two months before hospitalization (2%), paroxysm of atrial fibrillation (2%). Other reasons (18%) for not meeting inclusion criteria were significant thyroid dysfunction, recent thromboembolic events, angina at minimal exertion, anaemia with Hb < 9.0 mg/dl, severe peripheral atherosclerosis, acute myocarditis or pericarditis. Mean age was 60.9 AE 11.9 years and 90% were males. Of the 46 patients included into the study, 24 were randomized to the interval-training group and 22 to the control group. The first CPX test was performed 9.4 AE 3.7 days after hospital admission.
Baseline characteristics including concomitant medical therapy are presented in Table 1 . There was no difference in baseline demographic characteristics nor in medical history (except for history of stroke), aetiology of heart failure, severity of heart failure, kidney disease and concomitant therapy, except for amiodarone therapy linked to higher prevalence of paroxysmal atrial fibrillation in the training group. Patients with permanent atrial fibrillation were comparable to patients on basic sinus rhythm in terms of their baseline characteristics. Duration of intravenous loop diuretics administration before inclusion was 4.8 AE 6.0 days for the exercise training group and 5.0 AE 4.1 days for the control group. Average daily dose of intravenous furosemide was 54.7 AE 19.7 mg/day in the training group and 64.0 AE 40.4 mg/day in the control group. Up-titration of beta-blockers and angiotensin-converting enzyme inhibitors/angiotensin-II receptor blockers (ACEi/ARBs) was continued throughout the study in both groups. The relatively low percentage of patients receiving ACEi/ARBs at baseline is linked to hypotension or deterioration of renal function. By the time of discharge, 21 patients from the training group (87.5%) and 21 patients from the control group (95.5%) received ACEi/ARBs. By the end of the study, average dose of beta-blockers was 50.78 AE 31.61% (training) and 52.43 AE 21.13% (controls) from daily recommended dosage. Average dose of ACEi/ARBs was 39.29 AE 18.9% (training) and 38.11 AE 24.2% (controls) from maximal dosage. Digoxin was rarely prescribed because of its pro-arrhythmic effect and its insufficient effect on rate control with exertion. 16 Safety of early CPX and interval training after heart failure decompensation All patients were able to accomplish 6MWT and CPX with achievement of target RER. The main causes for test termination were exertional dyspnoea (41.3% of patients), volitional fatigue (32.6% of patients) and leg muscle pain (8.7% of patients). No life threatening complications were registered during CPX testing even in patients with LVEF < 20% (15.2% of all patients).
Two tests were complicated by arterial hypotension with systolic blood pressure less than 80 mmHg, and four tests by induction of frequent premature ventricular beats in the recovery period. All side-effects resolved spontaneously and did not require any additional medical intervention. These complications were not considered as a limitation for inclusion in the training programme. Baseline VO 2 peak and percentage from predicted values were relatively high for patients after an acute episode of heart failure decompensation, which may be partly explained by high prevalence of young males included in the study (Tables 1 and 2 ). Adverse events related to exercise training were not observed. Twenty of 24 patients randomized to the interval-training group completed the exercise programme. One drop-out was due to a hospitalization for acute cholecystitis, one patient refused to participate after discharge due to long travelling time to the hospital, and two patients were excluded because of poor compliance (completed less then 75% of the exercise training). In the control group, one patient died from sudden cardiac death 2.5 weeks after randomization. Two patients from the training group were re-hospitalized due to heart failure decompensation -at one and two months after completion of the exercise programme -and were excluded from further analysis. One patient refused to participate. In the control group two patients (9.5%) were re-hospitalized due to heart failure and one patient died (sudden cardiac death) nine weeks after enrolment. Seventeen patients in the exercise group and 18 patients in the control group were included in the final analysis.
Interval training and exercise tolerance
Interval training started 9.4 AE 3.7 days after hospitalization. Patients were trained at 71 AE 7.7% of maximal heart rate achieved with CPX. There were no serious complications during interval training. Seventeen patients completed 244 out of 255 scheduled training sessions, compliance rate with training regimen was 95.7%.
CPX results
After three weeks of interval training, exercise parameters significantly improved: VO 2 peak increased by 17.0% from 13.6 AE 2.9 to 15.9 AE 3.5 ml/min Â kg (p < 0.001) with further improvement of 9.4% after three months to 17.4 AE 4.3 ml/min Â kg (p ¼ 0.03). VO 2 peak expressed in % of VO 2 predicted significantly increased: from 56.0 AE 13.2% to 65.8 AE 16.1% (p < 0.001). In the control group, VO 2 peak in absolute values and expressed in % of VO 2 predicted did not change significantly after three weeks and slightly worsened after three months compared with three weeks, from 14.7 AE 4.1 to 14.1 AE 4.8 ml/min Â kg (p ¼ 0.04) (Table 2, Figure 2 ).
Mean heart rate at the maximal load during CPX was 121.8 AE 26.4 beats/min in the training group. During the first week of interval training, averaged heart rate during the training phase (excluding 
6MWT results
In the training group, 6MWT distance increased from 384.8 AE 111.5 m to 448.4 AE 108.8 m, while it remained without significant change in the control group (Table 2) .
ECHO data
LVEF, LVEDV and LVESV did not change significantly after three weeks in both groups, but there was a significant improvement observed in all of the measurements at the three months time point in the exercise training group (p ¼ 0.02 for LVEF, p ¼ 0.01 for LVEDV, p ¼ 0.004 for LVESV), without any changes in controls. However, there were no statistically significant differences between the two groups at any time point (Table 2) .
Exercise training and HRQoL
Quality of life measured by MLHFQ improved significantly in both groups after three weeks, but with better improvement in patients who trained -with Overall Summary Score changing from 65.2 AE 12.6 to 
Discussion
Interval exercise training starting as early as 9.4 AE 3.7 days after an episode of heart failure decompensation was safe and effective in improving exercise tolerance and HRQoL in selected systolic heart failure patients after achievement of clinical stability. Positive effects were sustained after three months. CPX was safely performed after careful selection in 19.6% of our study patients after hospitalization for heart failure decompensation.
The main causes of non-inclusion were standard contraindications for exercise testing and training, such as severe valvular problems, recent cardiovascular events and orthopaedic\neurologic limitations. Patients with recently implanted CRT devices were not included in the study to avoid the impact of CRT on exercise capacity. Patients with low GFR often presented with hypotension or muscle pain on exertion and were also excluded from the study. 17 However, some of these patients may be suitable for low intensity training under these circumstances. Drop-out rate from interval exercise training was 16.7% and did not exceed usual rates for cardiac rehabilitation programmes. Causes of quitting the programme were not directly related to the exercise training itself.
Our safety data are consistent with data from studies of Meyer et al. and Wisløff et al., in which there were also no serious complications during interval training programmes in heart failure patients. However, in these studies patients were included only after at least one or three months of clinically stable conditions. 18, 19 Nevertheless, recent investigations, for example the study of Acanfora et al., 20 where the patients were randomized to an exercise programme (combined aerobic and resistive activities) within two weeks after acute cardiogenic pulmonary oedema, demonstrate safety of training sessions early after heart failure decompensation. Still, there were some complications observed in studies with constant load exercise: in a study by Giannuzzi et al., 8 .9% of patients developed symptoms of decompensated heart failure during the course of training. This study also enrolled patients only after they had been in a stable condition for three months. 21 Although the steep ramp test is no longer widely used for evaluation of exercise training intensity, high intensity interval training (HIIT) is the actual favourite in exercise training in patients with heart failure, but not early after heart failure decompensation. Nevertheless, an early start of an interval training programme after heart failure decompensation using our approach seems feasible and is in line with recommendations for training in heart failure, where continuous or interval training is recommended in patients with VO 2 peak >10 to 18 ml/min Â kg or 300-450 m in the 6MWT. 2 Although we did not compare intervals, HIIT and constant load exercise modalities in our study, it seems that moderate intensity interval training (at approximately 70% of maximum heart rate achieved with CPX) is suitable in terms of safety early after heart failure decompensation in carefully selected patients. In fact, recent data from a large multicentre randomized trial show that HIIT may be not superior to moderate continuous training (MCT) in changing left ventricle function or exercise tolerance. Moreover, numerical differences in readmissions for worsening of heart failure suggested in favour of MCT relative to HIIT. 22 Efficiency of interval training was estimated by changes in VO 2 peak, echocardiography and HRQoL. The results of our study show that even a short period of exercise training can have a positive effect on exercise tolerance and quality of life. VO 2 peak increased by 17% after three weeks of interval training and did not In our study, three weeks of interval training had no significant effect on LVEF and left heart volumes within three weeks. However, slight improvements were registered in the training group at three months, although with no intergroup difference. This finding may indicate that longer periods may be necessary to achieve significant improvements. In a study with longer intervention periods, Wisløff et al. found that after 12 weeks of training notable changes were achieved: EDD LV (enddiastolic dimensions) decreased by 12%, ESD LV (end-systolic dimensions) by 15%, LVEDV by 18%, LVESV -by 25% and LVEF increased by 37%. 18 Similar results were shown in more recent study of Erbs et al., demonstrating significant improvement of left ventricle function in terms of LVESV, LVEDV and LVEF in advanced heart failure patients after 12 weeks of aerobic training. 23 According to the results from the MLHFQ questionnaire, our three-weeks interval training programme starting early after heart failure decompensation significantly improved quality of life in heart failure patients by a mean of 110.1%, whereas quality of life improved to a lesser extent, by 46.4%, in the control group. The improvement in the control group is considered to be connected to recovery from decompensation. In our study, results in regard to HRQoL improvement with exercise training differ from data from other studies. In a study by Belardinelli et al. using also the MLHFQ questionnaire, quality of life in chronic heart failure patients improved by 30% after two months of training, 6 and in the study by Smart et al. by 35.3% after 16 weeks of training. 24 However, the Acanfora study, including the patients shortly after decompensation, showed an almost two-fold reduction in MLHFQ score in training groups. 20 This indicates that early inclusion after heart failure decompensation into an exercise training programme could possibly lead to more prominent increases in quality of life scores compared with later inclusion. After three months, we noticed further improvement in quality of life in the training group, while the controls remained at the same level. This indicates that positive effects of a short course of interval training on VO 2 peak and quality of life may be sustained over longer periods and at least for three months.
Although mobilization and exercise training are generally recommended as soon as possible after decompensation in heart failure patients, 2 exercise training should not be started before patients are in a stable condition. 24 Studies conducted by Belardinelli and Smart included patients with stability for at least one month. Our study results indicate that it may be safe and effective to train stable patients as early as 9.4 AE 3.7 days after heart failure decompensation and in parallel to titrating heart failure medication. However, data on exercise training early after hospitalization for heart failure decompensation are rare and not yet conclusive. Therefore, there is the necessity to perform further research on this subject with a special emphasis on early exercise training, specific training modalities and long-term follow-up.
Limitations
A major limitation is that we included predominantly relatively young males excluding those with severe comorbidities, although this corresponds with some other studies about training in heart failure, for example in study of Adamopoulos et al. where mean age was even lower. 25 Therefore, our results cannot be extrapolated to different patient groups. The average length of hospital stay for heart failure decompensation still remains longer in Russia than in the EU and USA, which allowed us to initiate an exercise based rehabilitation programme with inpatients. This may have contributed to higher compliance and better results in the training group. Another limitation is the short duration of three weeks for the training intervention period. This is in contrast to general guidelines recommendation for longer-term continuous exercise training programmes for such patients. However, the aim of this study was to test safety and efficacy of an early start of interval exercise training. Therefore, participation in longerterm comprehensive rehabilitation programmes was offered to all patients after study termination. None of our patients had CRT devices or implantable cardioverter-defibrillators, mostly due to economic limitations; therefore, data cannot be extrapolated to such patients, although there is evidence that such patients may also benefit from exercise training. 26 Furthermore, our study included only patients with systolic heart failure, although there is evidence that in heart failure patients with preserved ejection fraction exercise training has various benefits as well, including improvements in exercise tolerance and quality of life. 27 
Conclusions
Starting moderate intensity interval exercise training early after systolic chronic heart failure decompensation is safe in selected patients -mainly younger patients with few comorbidities -when standard contraindications are observed and clinical stability is achieved. Exercise tolerance and quality of life may improve even after short time periods of exercise intervention and may last over longer time periods than expected. Further research is warranted to define the role and indications for interval training early after heart failure decompensation, in particular in different patient populations with higher risk for complications.
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